PCN DES 2026/27 · Network Contract

The PCN DES 2026/27 — explained, and built into our service.

The PCN DES 2026/27 (the Network Contract Directed Enhanced Service for Primary Care Networks) sets the priorities, the entitlements and the accountability for every PCN in England. Our service model is built around the PCN DES — so the pharmacist work we deliver in your network is the work the contract expects.
BCS aligned to the Network Contract DES 2026/27

ARRS roles

ARRS-compliant pharmacists and technicians.

Clinical pharmacists, pharmacy technicians and independent prescribers — all recruited and deployed in line with the Additional Roles Reimbursement Scheme. Every clinician meets the minimum role requirements set out in Annex B of the DES, with the experience profile, supervision and CPD evidence to back it up.

We recruit specifically for your PCN — not from a generic bench — so the clinician you get is the right fit for your practices, your cohorts and your workload.

Service requirements

The services the DES expects — delivered as standard.

Structured medication reviews, medicines reconciliation after hospital discharge, high-risk drug monitoring, repeat prescribing optimisation, long-term condition reviews and Enhanced Access cover — all part of our standard service, not paid extras.

Everything runs to one BCS protocol across every PCN we work with, so the standard of care your patients receive is the same whether you're in Halifax or Hammersmith.

Data, analytics & contract monitoring

Section 5.4 — answered by the BCS Impact Dashboard.

The DES makes contract monitoring and data submission a core PCN obligation. Our in-house BCS Impact Dashboard was built specifically to give Clinical Directors and ICB commissioners the evidence they need — reviews completed, high-risk patients managed, monitoring gaps closed, GP hours released and outcome trends over time.

Reports are generated monthly, shared quarterly, and available on-demand for ICB conversations and CQC preparation.

IIF, QOF and access

Moving patients to target — and proving it.

Our structured programmes are designed to move the indicators that matter — IIF performance, QOF achievement and the Capacity & Access Improvement Plan (CAIP). Hypertension control, cholesterol targets, diabetes optimisation, deprescribing and high-risk medicines monitoring all sit inside our standard delivery.

Progress is evidenced monthly in the Impact Dashboard, so your PCN can demonstrate movement against contract targets in real time, not at year end.

Care homes, frailty & neighbourhood working

Built for the PCN's wider population responsibilities.

The DES extends PCN accountability into care home rounds, frailty cohorts and Integrated Neighbourhood Team (INT) working. Our polypharmacy and frailty programme is structured around exactly these populations — patients 65+ on 8+ medications, care home residents and complex multimorbidity cohorts.

Our two-hub operational model (London and Halifax) gives us the coverage to scale this across neighbourhood populations without losing consistency of standard.

Quality assurance

We don't just quantify the work — we check the quality.

The DES sets the expectation. Our internal Quality Assurance framework makes sure we meet it. A structured audit cycle reviews a sample of every pharmacist's clinical work — medication reviews, prescribing decisions, monitoring follow-up and documentation — against BCS protocols and DES requirements.

Findings feed straight back into pharmacist supervision and our Training & Development team. Quality stays standardised, and the evidence is ready when the ICB or CQC asks.

Talk to our Service Development team

30-minute discovery call. We'll show you how BCS maps to your PCN's specific priorities.

Book a discovery call